New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
09:03 EDTATRS, DCTHAntares Pharma announces resignation of CEO Wotton, names Hobbs as CEO
Antares Pharma (ATRS) announced the resignation of Paul K. Wotton, Ph.D. who informed the company’s Board of Directors that he will assume the position of CEO of a development stage biotechnology company. Wotton also has resigned from the Antares Board of Directors. Antares Pharma also announced today the appointment of Eamonn P. Hobbs to the position of President and CEO of the company effective immediately. Hobbs joined the Antares Board of Directors in August 2009 and has over 30 years of experience in the pharmaceutical, medical device, and combination products industry, including the medical specialty fields of radiology, vascular surgery, interventional cardiology, oncology and gastroenterology. Hobbs was previously the President and CEO of Delcath Systems (DCTH).
News For ATRS;DCTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
07:06 EDTATRSAntares Pharma regains U.S. marketing rights to Otrexup for psoriasis
Subscribe for More Information
April 23, 2015
10:07 EDTDCTHDelcath Systems management to meet with Roth Capital
Subscribe for More Information
April 22, 2015
07:11 EDTDCTHCardiovascular & Interventional Radiological Society of Europe holds conference
Subscribe for More Information
April 21, 2015
08:06 EDTDCTHDelcath Systems approves amendments to its CTAs filed in U.K. and Germany
Delcath Systems announces approval of amendments to its Clinical Trial Authorizations, or CTAs, filed with the U.K.'s Medicines and Healthcare Products Regulatory Agency and Germany's Federal Institute for Drugs and Medical Devices for the expansion of the Company's global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma, to include a cohort of patients with intrahepatic cholangiocarcinoma.
April 16, 2015
07:20 EDTATRSAntares Pharma announces settlement of patent infringement lawsuits
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use